Targeting transforming growth factor-β1 by methylseleninic acid/seleno-L-methionine in clear cell renal cell carcinoma: Mechanisms and therapeutic potentialAseel O. Rataan, Aliasger K. Salem|Cancer Treatment and Research Communications|2024Cited by 2
Phase I Clinical Trial of High Doses of Seleno-L-methionine in Combination with Axitinib in Patients with Previously Treated Metastatic Clear-cell Renal Cell CarcinomaYousef Zakharia, Youcef M. Rustum, Matthew R. Kroll et al.|Clinical Cancer Research|2025Cited by 1